A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation X Luo, Y Ikeda, KL Parker Cell 77 (4), 481-490, 1994 | 1888 | 1994 |
Improvement in outcomes of clinical islet transplantation: 1999–2010 FB Barton, MR Rickels, R Alejandro, BJ Hering, S Wease, B Naziruddin, ... Diabetes care 35 (7), 1436-1445, 2012 | 898 | 2012 |
Phase 3 trial of transplantation of human islets in type 1 diabetes complicated by severe hypoglycemia BJ Hering, WR Clarke, ND Bridges, TL Eggerman, R Alejandro, MD Bellin, ... Diabetes care 39 (7), 1230-1240, 2016 | 706 | 2016 |
The nuclear receptor steroidogenic factor 1 acts at multiple levels of the reproductive axis. HA Ingraham, DS Lala, Y Ikeda, X Luo, WH Shen, MW Nachtigal, ... Genes & development 8 (19), 2302-2312, 1994 | 703 | 1994 |
The nuclear receptor steroidogenic factor 1 is essential for the formation of the ventromedial hypothalamic nucleus. Y Ikeda, X Luo, R Abbud, JH Nilson, KL Parker Molecular endocrinology 9 (4), 478-486, 1995 | 495 | 1995 |
Dendritic cell–expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice KV Tarbell, L Petit, X Zuo, P Toy, X Luo, A Mqadmi, H Yang, ... The Journal of experimental medicine 204 (1), 191-201, 2007 | 464 | 2007 |
Characterization of the mouse FTZ-F1 gene, which encodes a key regulator of steroid hydroxylase gene expression. Y Ikeda, DS Lala, X Luo, E Kim, MP Moisan, KL Parker Molecular endocrinology 7 (7), 852-860, 1993 | 439 | 1993 |
Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis DR Getts, AJ Martin, DP McCarthy, RL Terry, ZN Hunter, WT Yap, ... Nature biotechnology 30 (12), 1217-1224, 2012 | 427 | 2012 |
Steroidogenic factor 1: an essential mediator of endocrine development KL Parker, DA Rice, DS Lala, Y Ikeda, X Luo, M Wong, M Bakke, L Zhao, ... Recent progress in hormone research 57 (1), 19-36, 2002 | 406 | 2002 |
Dendritic cells with TGF-β1 differentiate naive CD4+ CD25− T cells into islet-protective Foxp3+ regulatory T cells X Luo, KV Tarbell, H Yang, K Pothoven, SL Bailey, R Ding, RM Steinman, ... Proceedings of the National Academy of Sciences 104 (8), 2821-2826, 2007 | 353 | 2007 |
Tolerance induced by apoptotic antigen-coupled leukocytes is induced by PD-L1+ and IL-10–producing splenic macrophages and maintained by T regulatory cells DR Getts, DM Turley, CE Smith, CT Harp, D McCarthy, EM Feeney, ... The Journal of Immunology 187 (5), 2405-2417, 2011 | 222 | 2011 |
Impairing oral tolerance promotes allergy and anaphylaxis: a new murine food allergy model K Ganeshan, CV Neilsen, A Hadsaitong, RP Schleimer, X Luo, PJ Bryce Journal of Allergy and Clinical Immunology 123 (1), 231-238. e4, 2009 | 211 | 2009 |
ECDI-fixed allogeneic splenocytes induce donor-specific tolerance for long-term survival of islet transplants via two distinct mechanisms X Luo, KL Pothoven, D McCarthy, M DeGutes, A Martin, DR Getts, G Xia, ... Proceedings of the National Academy of Sciences 105 (38), 14527-14532, 2008 | 203 | 2008 |
MerTK cleavage on resident cardiac macrophages compromises repair after myocardial ischemia reperfusion injury M DeBerge, XY Yeap, S Dehn, S Zhang, L Grigoryeva, S Misener, ... Circulation research 121 (8), 930-940, 2017 | 190 | 2017 |
Immunotherapy of type 1 diabetes: where are we and where should we be going? X Luo, KC Herold, SD Miller Immunity 32 (4), 488-499, 2010 | 182 | 2010 |
NIH-sponsored clinical islet transplantation consortium phase 3 trial: manufacture of a complex cellular product at eight processing facilities C Ricordi, JS Goldstein, AN Balamurugan, GL Szot, T Kin, C Liu, ... Diabetes 65 (11), 3418-3428, 2016 | 178 | 2016 |
Advancing islet transplantation: from engraftment to the immune response RF Gibly, JG Graham, X Luo, WL Lowe, BJ Hering, LD Shea Diabetologia 54, 2494-2505, 2011 | 165 | 2011 |
Pathogenesis of NOD diabetes is initiated by reactivity to the insulin B chain 9-23 epitope and involves functional epitope spreading S Prasad, AP Kohm, JS McMahon, X Luo, SD Miller Journal of autoimmunity 39 (4), 347-353, 2012 | 136 | 2012 |
Improved health-related quality of life in a phase 3 islet transplantation trial in type 1 diabetes complicated by severe hypoglycemia ED Foster, ND Bridges, ID Feurer, TL Eggerman, LG Hunsicker, ... Diabetes care 41 (5), 1001-1008, 2018 | 129 | 2018 |
Systemic transforming growth factor-β1 gene therapy induces Foxp3+ regulatory cells, restores self-tolerance, and facilitates regeneration of beta cell function in overtly … X Luo, H Yang, IS Kim, F Saint-Hilaire, DA Thomas, BP De, E Ozkaynak, ... Transplantation 79 (9), 1091-1096, 2005 | 128 | 2005 |